The Digital Biomarker Company: AI-Powered Digital Biomarkers for Predictive Vital Sign Changes

Others tell you how you slept last night. TDBC tells you what will happen next.

Powered by the proprietary nFOPT™ sensor and trained on millions of hours of biomarker data, TDBC uses AI health analytics to deliver early issue identification and predictive condition change alerts. From detecting sleep disorders including sleep apnea, to providing real-time alerts in elderly care and remote monitoring, to supporting management of chronic conditions such as cardiovascular and respiratory disease, our contactless technology empowers medical professionals and carers to act before problems escalate and drive positive outcomes. Thanks to its straightforward setup and ease of use, the system integrates seamlessly into chronic home care programs, reducing resource burden and delivering economic efficiency for heath services worldwide. 

Two researchers analyzing AI-powered neural network data visualization, representing TDBC digital biomarkers and predictive condition change technology with nFOPT sensor.

About TDBC: Advancing Predictive Condition Change

Singapore skyline with futuristic digital biomarker data overlay, representing TDBC global expansion of nFOPT sensor and AI predictive condition change technology.
TDBC is a Singapore-based health technology company pioneering the use of digital biomarkers to transform care. Our mission is to shift healthcare from retrospective tracking to predictive condition change alerts that warn clinicians and carers before issues escalate. By combining the ultrasensitive nFOPT™ sensor, a vast biomarker database, and advanced AI health analytics, TDBC delivers actionable insights for sleep apnea detection, elderly care, and chronic condition management. TDBC builds on the pioneering work of Huijia Health in Taiwan and is taking the proven nFOPT™ sensor technology to a global stage.

The TDBC Solution: nFOPT™ Sensor · Biomarker Database · AI Analytic Algorithm

At the heart of TDBC is a three-pillar platform that captures, analyzes, and transforms raw physiological signals into predictive condition change alerts for medical professionals and carers. Not only can this improve patient outcomes, it can also help to save cost for care in the home, care in the community, in residential care homes, in hospitals and more.

nFOPT stands for “non-invasive Fiber Optic Physiological monitoring Technology.” 

nFOPT™ Sensor

nFOPT sensor with fiber optic and heart waveform background, representing TDBC contactless digital biomarker technology for predictive condition change alerts.

The contactless, ultrasensitive nFOPT™ fiber-optic sensor captures micro-movements, respiration, and subtle biomarker signals, all without the need for wearables, electrodes, or wires and without electromagnetic interference.

Biomarker Database

Cloud-based biomarker database with heartbeat and respiration waveforms, representing TDBC’s millions of hours of validated health and sleep data powering predictive condition change alerts.
A global-scale biomarker repository with millions of hours of validated sleep and health data. This database powers unmatched accuracy in issue identification and predictive alerts based on the enhanced data-collection ability and design of the ultra sensitive nFOPT™ Sensor.

AI Analytic Algorithm

Neural network diagram symbolizing TDBC’s AI analytic algorithm that transforms biomarker data into predictive condition change alerts for clinicians and carers.
Our proprietary AI engine transforms complex biomarker data into predictive condition change alerts, helping clinicians and carers intervene before problems escalate and increasing the opportunity to create positive patient outcomes.

Why TDBC? From Issue Identification to Predictive Condition Change Alerts

Futuristic globe with biomarker waveforms and digital alert icons, symbolizing TDBC predictive condition change technology and AI health analytics on a global scale.

Unlike traditional trackers that only record past data, TDBC delivers alerts that matter:

  • Issue Identification — highlight emerging health problems at the earliest stage

  • Predictive Condition Change Alerts — forecast deterioration before symptoms escalate

  • Contactless Monitoring — no wearables, electrodes, or patient discomfort

  • Clinically Validated — accuracy benchmarked against polysomnography (PSG), the gold standard in sleep diagnostics

  • Proven in Real-World Use — extensively deployed in Taiwan over recent years, particularly in elderly care homes, where it has demonstrated measurable impact on reducing emergency incidents

  • Data-Driven — supported by one of the world’s largest biomarker databases, with algorithms refined through millions of hours of real patient data

  • Scalable & Versatile — adaptable for use at home, in elderly care, and across hospitals

 

Not just tracking. TDBC predicts.

Health Applications: From Sleep Apnea to Elderly Care and Beyond

TDBC’s predictive biomarker technology has wide-reaching applications across healthcare and more. By combining contactless sensing, a proven biomarker database, and AI analytic algorithms, TDBC delivers condition change alerts that improve outcomes in sleep medicine, elderly care, hospital monitoring, and chronic disease management.

Use Case 1: Sleep Apnea & Sleep Disorders

Comparison of traditional sleep apnea measurement with multiple wires and sensors versus TDBC nFOPT™ contactless sleep apnea monitoring in a sleep lab.

Traditional sleep studies require patients to wear multiple electrodes and wires, disrupting natural rest. The nFOPT™ sensor provides contactless, PSG-equivalent monitoring in the comfort of a patient’s own bed. This improves patient compliance and comfort while delivering clinically validated insights.

Use Case 2: Elderly Care Homes

Elderly care residents monitored by TDBC biomarker technology, showing predictive condition change alert for one patient and green biomarker checks for others, with a caregiver receiving an early warning notification.

In elderly care, TDBC enables continuous monitoring of residents without intrusion. Care staff receive predictive alerts on breathing irregularities or deteriorating conditions, allowing interventions before emergencies escalate. Deployed in Taiwan, the system has already demonstrated its ability to reduce emergency incidents and improve care outcomes and also, significantly reduced care costs. 

Use Case 3: Hospital Monitoring

Nurse in a hospital ward monitoring predictive biomarker alerts on a digital tablet with TDBC technology, while patients rest in beds for continuous contactless health monitoring.

TDBC provides clinical-grade monitoring without patient discomfort, freeing staff from routine vital sign checks and enabling earlier intervention. The AI algorithm delivers predictive alerts, helping hospitals reduce workload while improving patient safety.

Use Case 4: Chronic Condition Management at Home

Doctor monitoring a patient with chronic conditions remotely using TDBC predictive biomarker data, showing health waveforms and alerts on digital screens while the patient rests at home.

For patients with cardiovascular, respiratory, or other chronic conditions, TDBC enables continuous home monitoringwith predictive alerts that support proactive care and reduce hospital admissions. The nFOPT™ sensor is simple to install and effortless to use; patients only need to place it under the mattress or cushion, with no wearables, wires, or technical setup required. This ease of use ensures higher compliance, more reliable data, and better long-term health outcomes.

Use Case 5: Safety-Critical Professions - Beyond Health

Composite image showing an airline pilot in a cockpit and a truck driver in a cab, both with predictive biomarker monitoring overlays, representing TDBC safety applications in aviation and transportation.

Beyond healthcare, TDBC’s predictive biomarker technology delivers powerful advantages in industries where safety and performance depend on human vigilance. For pilots, drivers, industrial workers, or defense personnel, fatigue and undetected health deterioration can lead to catastrophic outcomes. By monitoring subtle biomarker changes and issuing predictive alerts before accidents occur, TDBC enhances operational safety, reduces risk, and protects lives in high-stakes environments.

The TDBC Leadership Team

CEO

Michael Taube

25+ years of experience in medical technology and devices, including leadership roles such as Marketing Manager at Philips, Business Unit Director at GE HealthCare, VP & GM at ResMed, CMO at Ivoclar, COO at Otivio and GM at OrthoApnea.

CCO

Guy Beckerlegge

20 years in the medical, health, and wellness sectors across the US, EU, and Asia. Founder of several medical device companies and multiple health-related businesses. Expertise in business development, sales, regulatory and certification, medical device distribution, and market access.

CTO / CPO

Eric Djie

30 years in startup, design, and product development across various categories. Experience in SaaS, IoT, and awarded product design. Co-founder and CEO of the company that developed NASA’s tablet PC for astronauts (2009–2014). Holds a degree in medicine and several functional and aesthetic patents.

COO

David Ring

Extensive experience in high-volume electronics manufacturing, business development and operations across a wide range of sectors. Proven ability to manage complex cross-border projects and drive product innovation and profitability at scale.

Huijia Health Life Technology Team

A key support element of TDBC.

Contact TDBC

12 + 11 =